3/13
05:39 am
kros
Keros Therapeutics initiated with a Not Rated at Goldman Sachs
Low
Report
Keros Therapeutics initiated with a Not Rated at Goldman Sachs
3/13
05:39 am
kros
Keros Therapeutics initiated with a Not Rated at Goldman Sachs
Low
Report
Keros Therapeutics initiated with a Not Rated at Goldman Sachs
3/13
05:39 am
kros
Keros Therapeutics initiated with a Not Rated at Goldman Sachs
Low
Report
Keros Therapeutics initiated with a Not Rated at Goldman Sachs
3/1
08:14 am
kros
Keros Therapeutics, Inc. (NASDAQ: KROS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
Low
Report
Keros Therapeutics, Inc. (NASDAQ: KROS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
2/29
11:12 am
kros
Keros Therapeutics, Inc. (NASDAQ: KROS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $86.00 price target on the stock.
Low
Report
Keros Therapeutics, Inc. (NASDAQ: KROS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $86.00 price target on the stock.
2/29
11:12 am
kros
Keros Therapeutics, Inc. (NASDAQ: KROS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $86.00 price target on the stock.
Low
Report
Keros Therapeutics, Inc. (NASDAQ: KROS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $86.00 price target on the stock.
2/21
07:27 am
kros
Keros Therapeutics, Inc. (NASDAQ: KROS) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Low
Report
Keros Therapeutics, Inc. (NASDAQ: KROS) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
2/21
07:27 am
kros
Keros Therapeutics, Inc. (NASDAQ: KROS) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Low
Report
Keros Therapeutics, Inc. (NASDAQ: KROS) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.